Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Systemic Levels of Anti-VEGF: What Available Data Reveal

  Channels: Retina | Posted 1/16/2014

Robert L. Avery, MD, discusses the recent finding from CATT, IVAN on systemic concentrations of bevacizumab and ranibizumab after injection, the EPAR report in regard to the systemic safety of aflibercept, and his own study on serum levels of anti-VEGF drug levels (bevacizumab, ranibizumab, and aflibercept) and free VEGF in human plasma.

Age-Related Macular Degeneration • AMD • Anti-VEGF • Bevacizumab • Diabetic macular edema, DME • Ranibizumab • Retina

Related Videos